Veedol Corporation Limited (NSE:VEEDOL)
1,416.60
-7.70 (-0.54%)
Jan 23, 2026, 3:30 PM IST
Veedol Corporation Revenue
Veedol Corporation had revenue of 5.09B INR in the quarter ending September 30, 2025, with 6.93% growth. This brings the company's revenue in the last twelve months to 20.38B, up 5.15% year-over-year. In the fiscal year ending March 31, 2025, Veedol Corporation had annual revenue of 19.70B with 1.96% growth.
Revenue (ttm)
20.38B
Revenue Growth
+5.15%
P/S Ratio
1.18
Revenue / Employee
42.20M
Employees
483
Market Cap
24.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 19.70B | 378.80M | 1.96% |
| Mar 31, 2024 | 19.33B | 788.10M | 4.25% |
| Mar 31, 2023 | 18.54B | 3.18B | 20.71% |
| Mar 31, 2022 | 15.36B | 2.77B | 22.03% |
| Mar 31, 2021 | 12.58B | -580.90M | -4.41% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Savita Oil Technologies | 40.16B |
| Rossari Biotech | 22.91B |
| S H Kelkar and Company | 22.41B |
| Jubilant Agri and Consumer Products | 17.51B |
| NOCIL | 13.15B |
| Neogen Chemicals | 8.00B |
| Advanced Enzyme Technologies | 7.07B |
| Jai Corp | 6.65B |